Macugen Side Effects
Generic Name: pegaptanib ophthalmic
Note: This document contains side effect information about pegaptanib ophthalmic. Some of the dosage forms listed on this page may not apply to the brand name Macugen.
Some side effects of Macugen may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to pegaptanib ophthalmic: intraocular solution
Along with its needed effects, pegaptanib ophthalmic (the active ingredient contained in Macugen) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking pegaptanib ophthalmic:More common
- Bladder pain
- bloody eye
- bloody or cloudy urine
- blurred vision
- burning, dry, or itching eyes
- cough producing mucus
- decreased vision or other changes in vision
- difficult, burning, or painful urination
- difficulty breathing
- discharge, excessive tearing
- disturbed color perception
- double vision
- drainage from eyes
- eye pain
- frequent urge to urinate
- gradual loss of vision
- halos around lights
- itching of eyelid
- looking through water
- lower back or side pain
- night blindness
- overbright appearance of lights
- painful irritation of the clear front part of the eye
- redness, pain, swelling of eye, eyelid, or inner lining of eyelid
- seeing flashes or sparks of light
- seeing floating spots before the eyes
- shortness of breath
- sore eyes
- swelling of the eye
- tightness in chest
- tunnel vision
- Bigger, dilated, or enlarged pupils (black part of the eye)
- change in vision not present before treatment
- chest pain
- decrease in frequency of urination
- decrease in urine volume
- difficulty in passing urine (dribbling)
- dizziness or lightheadedness
- dry mouth
- eye irritation
- feeling of constant movement of self or surroundings
- flushed, dry skin
- fruit-like breath odor
- hearing loss
- inability to speak
- increased hunger
- increased sensitivity of eyes to light
- increased thirst
- increased urination
- loss of consciousness
- numbness or tingling in face, arms, or legs
- seeing floaters, veil or curtain appearing across part of vision
- sensation of spinning
- severe or sudden headache
- slurred speech
- temporary blindness
- trouble speaking, thinking, or walking
- troubled breathing
- unexplained weight loss
- weakness in arm and/or leg on one side of the body, sudden and severe
- Difficulty swallowing
- fast heartbeat
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- skin rash
- unusual tiredness or weakness
Some side effects of pegaptanib ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:More common
- Acid or sour stomach
- blistering, burning, crusting, dryness, or flaking of skin
- difficulty in moving
- itching, scaling, severe redness, soreness, swelling of skin
- muscle pain or stiffness
- pain, swelling, or redness in joints
- stomach discomfort, upset, or pain
For Healthcare Professionals
Applies to pegaptanib ophthalmic: intraocular solution
Ocular side effects classified as serious have included endophthalmitis, retinal detachment, and iatrogenic traumatic cataract in <1% of patients. Anterior chamber inflammation, blurred vision, cataract, conjunctival hemorrhage, corneal edema, eye discharge, eye irritation, eye pain, hypertension, increased intraocular pressure, ocular discomfort, punctate keratitis, reduced visual acuity, visual disturbance, vitreous floaters, and vitreous opacities have been reported in 10% to 40% of patients. Blepharitis, conjunctivitis, photopsia, and vitreous disorder have been reported in 6% to 10% of patients. Allergic conjunctivitis, conjunctival edema, corneal abrasion, corneal deposits, corneal epithelium disorder, eye inflammation, eye swelling, eyelid irritation, meibomianitis, mydriasis, periorbital hematoma, retinal edema, and vitreous hemorrhage have been reported in 1% to 5% of patients.
Respiratory side effects have included bronchitis (6% to 10%) and pleural effusion (1% to 5%) of patients.
Gastrointestinal side effects have included diarrhea (6% to 10%), nausea (6% to 10%), vomiting (1% to 5%), and dyspepsia (1% to 5%).
Nervous system side effects have included dizziness (6% to 10%), headache (6% to 10%), and hearing loss (1% to 5%).
Musculoskeletal side effects have included arthritis, bone spur, and contusion in 1% to 5% of patients.
Cardiovascular side effects have included carotid artery occlusion, cerebrovascular accident, chest pain, and transient ischemic attack in 1% to 5% of patients.
Dermatologic side effects have included contact dermatitis in 1% to 5% of patients.
Genitourinary side effects have included urinary tract infection (6% to 10%) and urinary retention (1% to 5%).
Metabolic side effects have included diabetes mellitus in 1% to 5% of patients.
Hypersensitivity side effects have rarely included anaphylaxis and/or anaphylactoid reactions, including angioedema. However, causality has not been established.
More about Macugen (pegaptanib ophthalmic)
Compare with other treatments for:
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.